Literature DB >> 7016596

Blood pressure regulation: basic concepts.

A C Guyton, J E Hall, T E Lohmeier, T E Jackson, P R Kastner.   

Abstract

In this paper we have attempted to explain the difference between proportional pressure control systems and the renal-blood volume-pressure control mechanism, which is an infinite gain pressure control system. Because of this infinite gain of the kidney mechanism, this mechanism has the capability of returning arterial pressure all the way back to the control leve. Furthermore, this mechanism can override the other pressure control mechanisms because of its extreme control capability. On the other hand, the renal-blood volume mechanism for pressure control itself be controlled by many other factors. These other factors are said to change the pressure "set-point" level of the renal system, and then the renal system automatically brings the pressure to the set-point level. It is especially noteworthy, however, that some of the factors that play extreme roles in short-term pressure control-such as heart strength, vascular capacity, and total peripheral resistance-will not alter the long-term arterial pressure level (unless they in some way concurrently alter the set-point of the kidney mechanism).

Mesh:

Substances:

Year:  1981        PMID: 7016596

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  7 in total

1.  Nitric oxide produced by endothelial nitric oxide synthase promotes diuresis.

Authors:  Jazmin M Perez-Rojas; Kamal M Kassem; William H Beierwaltes; Jeffrey L Garvin; Marcela Herrera
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

2.  Sodium handling by the Sabra hypertension prone (SBH) and resistant (SBN) rats.

Authors:  Y Yagil; J Mekler; H Wald; M M Popovtzer; D Ben-Ishay
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

3.  Twenty four hour intermittent, ambulatory blood pressure monitoring.

Authors:  M Egger; M G Bianchetti; M Gnädinger; R Kobelt; O Oetliker
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

4.  The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension.

Authors:  Gary L Schwartz; Kent Bailey; Arlene B Chapman; Eric Boerwinkle; Stephen T Turner
Journal:  Am J Hypertens       Date:  2013-04-16       Impact factor: 2.689

5.  Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension.

Authors:  Kamel A Gharaibeh; Stephen T Turner; Abdurrahman M Hamadah; Arlene B Chapman; Rhonda M Cooper-Dehoff; Julie A Johnson; John G Gums; Kent R Bailey; Gary L Schwartz
Journal:  Am J Hypertens       Date:  2016-06-30       Impact factor: 2.689

6.  Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension.

Authors:  Mai Mehanna; Yan Gong; Caitrin W McDonough; Amber L Beitelshees; John G Gums; Arlene B Chapman; Gary L Schwartz; Julie A Johnson; Stephen T Turner; Rhonda M Cooper-DeHoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-21       Impact factor: 3.738

7.  ACE I/D Polymorphism in Hypertensive Patients of Kashmiri Population.

Authors:  A Syed Sameer; Nidda Syeed; Shahid A Tak; Samina Bashir; Saniya Nissar; Mushtaq A Siddiqi
Journal:  Cardiol Res       Date:  2010-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.